Don't expect first Covid-19 vaccinations until early 2021, says WHO expert

WHO is working hard to ensure fair distribution of the vaccines, but in the meantime it is key to suppress the spread of the virus, said Mike Ryan, executive director of WHO's emergencies programme

covid-19, vaccine, coronavirus
WHO was working to expand access to potential vaccines and to help scale-up production capacity, Ryan said.
Reuters Geneva
2 min read Last Updated : Jul 22 2020 | 11:10 PM IST
Researchers are making "good progress" in developing vaccines against Covid-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World Health Organization (WHO) expert said on Wednesday.
 
WHO is working hard to ensure fair distribution of the vaccines, but in the meantime it is key to suppress the spread of the coronavirus, said Mike Ryan, executive director of WHO's emergencies programme, as daily new cases around the globe are at near-record levels.
 
"We're making good progress," Ryan said, noting that several vaccines were now in phase 3 trials and none had failed, so far, in terms of safety or ability to generate an immune response.
 
"Realistically it is going to be the first part of next year before we start seeing people getting vaccinated," he told a public event on social media.
 
WHO was working to expand access to potential vaccines and to help scale-up production capacity, Ryan said.
 
"And we need to be fair about this, because this is a global good. Vaccines for this pandemic are not for the wealthy, they are not for the poor, they are for everybody," he said.
 
The US government will pay $1.95 billion to buy 100 million doses of a Covid-19 vaccine being developed by Pfizer Inc and German biotech BioNTech if it proves safe and effective, the companies said earlier on Wednesday.
 


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusWorld Health OrganizationCoronavirus Vaccine

Next Story